| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Earnings before income tax expense | 714 | 1,554 | 1,661 | 2,084 |
| Income tax expense | 526 | 613 | 372 | 520 |
| Net earnings | 188 | 941 | 1,289 | 1,564 |
| Net earnings attributable to noncontrolling interest | 2 | 3 | 3 | 3 |
| Net earnings attributable to abbvie inc | 186 | 938 | 1,286 | 1,561 |
| Basic earnings per share (in dollars per share) | 0.1 | 0.52 | 0.72 | 0.88 |
| Diluted earnings per share (in dollars per share) | 0.1 | 0.52 | 0.72 | 0.88 |
| Weighted-average basic shares outstanding (in shares) | 1,769,000,000 | 1,768,000,000 | 1,768,000,000 | 1,769,000,000 |
| Weighted-average diluted shares outstanding (in shares) | 1,772,000,000 | 1,771,000,000 | 1,772,000,000 | 1,772,000,000 |
AbbVie Inc. (ABBV)
AbbVie Inc. (ABBV)